Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 8
2021 13
2022 28
2023 27
2024 10
2025 14
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Integrating Network Pharmacology to Investigate the Mechanism of Ginsenoside Compound K Against Coronavirus.
Qu Z, Wang Y, Yu H, Xu S. Qu Z, et al. J Phys Chem B. 2026 Jan 8;130(1):299-310. doi: 10.1021/acs.jpcb.5c07771. Epub 2025 Dec 19. J Phys Chem B. 2026. PMID: 41419235
Among promising candidates, ginsenoside compound K (CK)-a bioactive metabolite derived from Panax ginseng-has emerged with preliminary evidence indicating its potential anticoronavirus activity. ...Functional enrichment analysis revealed CK's involvement in critical …
Among promising candidates, ginsenoside compound K (CK)-a bioactive metabolite derived from Panax ginseng-has emerged with pre …
Korean red ginseng mitigates pulmonary injury and enhances antiviral immunity in a low-dose pseudo-type SARS-CoV-2 infection model.
Gu GR, Kim HJ, Jang WY, Lim HK, Hwang JY, Oh Y, Oh J, Youn SH, Hyun SH, Park JH, Ko HK, Lee SH, Hwang J, Moon S, Kweon DH, Cho JY, Kim HG. Gu GR, et al. J Ginseng Res. 2025 Nov;49(6):671-682. doi: 10.1016/j.jgr.2025.05.009. Epub 2025 Jun 5. J Ginseng Res. 2025. PMID: 41268306 Free PMC article.
OBJECTIVE: and design: This research was conducted to investigate the immunomodulatory and anti-inflammatory effects of Korean red ginseng in a low-dose pseudo-type SARS-CoV-2 (PSV) infection model using hACE2 transgenic mice. ...Our data also support …
OBJECTIVE: and design: This research was conducted to investigate the immunomodulatory and anti-inflammatory effects of Korean red ginsen …
[Herbal treatment options for post-viral symptoms and long COVID].
Krassnig K, Bauer R, Glasl S, Haubenberger P, Evanzin HJ, Schneider K, Margotti D. Krassnig K, et al. Wien Med Wochenschr. 2025 Oct 29. doi: 10.1007/s10354-025-01113-8. Online ahead of print. Wien Med Wochenschr. 2025. PMID: 41160239 Review. German.
BACKGROUND: Long COVID and post-viral symptom complexes have become a significant focus in medical practice. ...The review identified the most relevant medicinal plants and their preparations for the most common symptom complexes of long COVID. RESULTS: A total of 9 …
BACKGROUND: Long COVID and post-viral symptom complexes have become a significant focus in medical practice. ...The review identified …
Ginseng as promising natural medicine against infectious diseases: Therapeutic targets and potential mechanisms.
Song Y, Zhang S, Wang R, Zhang Y, Zhang Y, Lin H, Wang F. Song Y, et al. J Ethnopharmacol. 2026 Feb 10;356:120764. doi: 10.1016/j.jep.2025.120764. Epub 2025 Oct 19. J Ethnopharmacol. 2026. PMID: 41120028 Review.
This review integrates ethnomedical insights with contemporary pharmacology, highlighting ginseng's translational potential in combating antimicrobial resistance and emerging infectious diseases. ...They also demonstrate synergistic effects with conventional therapi …
This review integrates ethnomedical insights with contemporary pharmacology, highlighting ginseng's translational potential in …
Network Pharmacology and Experiment Verification-Based Strategy for Exploring the Mechanisms of Shuqing Granule in the Treatment of COVID-19.
Guo X, Zheng H, An Y, Song Y, Liu T, Zhou Z, Liu C, Wang G, Wang F. Guo X, et al. Pharmaceuticals (Basel). 2025 Aug 18;18(8):1216. doi: 10.3390/ph18081216. Pharmaceuticals (Basel). 2025. PMID: 40872607 Free PMC article.
It exhibits anti-inflammatory and antiviral activities as well as broad-spectrum antiviral effects, yet its potential role in the treatment of COVID-19 remains unclear. This study thus aimed to explore the therapeutic effects of SG on COVID-19, with a …
It exhibits anti-inflammatory and antiviral activities as well as broad-spectrum antiviral effects, yet its potential role in the treatment …
The effects of G1899 Korean red ginseng extract powder on long COVID for acute COVID19 infection: A randomized, double-blind, placebo-controlled trial.
Seo IH, Park B, Kim H, Heo SJ, Jung DH. Seo IH, et al. J Ginseng Res. 2025 Jul;49(4):470-477. doi: 10.1016/j.jgr.2025.04.007. Epub 2025 Apr 24. J Ginseng Res. 2025. PMID: 40621076 Free PMC article.
BACKGROUND: In this study, we investigated the therapeutic potential effects of G1899 Korean Red Ginseng Extract Powder(G1899) on long COVID in a general population using flow cytometry and follow-up by questionnaire. ...Participants were randomized 1:1 to the G1899 …
BACKGROUND: In this study, we investigated the therapeutic potential effects of G1899 Korean Red Ginseng Extract Powder(G1899) on lon …
Antiviral potential of ginseng: Targeting human pathogenic viruses with compounds derived from ginseng.
Huo C, Baek J, Kim KH. Huo C, et al. J Ginseng Res. 2025 Mar;49(2):105-117. doi: 10.1016/j.jgr.2024.12.004. Epub 2024 Dec 10. J Ginseng Res. 2025. PMID: 40061485 Free PMC article. Review.
The COVID-19 pandemic has highlighted the critical need for effective antiviral therapies, as viral infections remain a leading cause of mortality worldwide. ...This review examines the antiviral compounds from ginseng that act against various human pathogeni …
The COVID-19 pandemic has highlighted the critical need for effective antiviral therapies, as viral infections remain a leadin …
Korean Red Ginseng relieves the inflammation and oxidative stress induced by pseudo-typed SARS-CoV-2.
Kim HJ, Oh Y, Moon S, Oh J, Kim JH, Lee SH, Hyun SH, Park JH, Ko HK, Hwang J, Kim HG, Kweon DH, Cho JY. Kim HJ, et al. J Ginseng Res. 2025 Mar;49(2):166-178. doi: 10.1016/j.jgr.2024.11.004. Epub 2024 Nov 23. J Ginseng Res. 2025. PMID: 40061481 Free PMC article.
BACKGROUND: Developing antiviral agents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a global goal since the Coronavirus Disease 2019 (COVID-19) pandemic emerged in 2019. Korean Red Ginseng (KRG), r …
BACKGROUND: Developing antiviral agents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has …
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial.
Fielding RA, Dao MM, Cannon K, Desvarieux M, Miller SS, Gimness MP, Brandon DM, Villareal DT, Bruyere O, Bautmans I, Rickner K, Perry R, Kritchevsky SB, Musi N, Chehade JM, Kirstein JL, Gielen E, Pickrell P, Dilda P, Lafont R, Margalef C, Rolland Y, Del Signore S, Mariani J, Agus S, Tourette C, Dioh W, van Maanen R, Veillet S. Fielding RA, et al. J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13750. doi: 10.1002/jcsm.13750. J Cachexia Sarcopenia Muscle. 2025. PMID: 40026058 Free PMC article. Clinical Trial.
RESULTS: A total of 233 participants were randomised (mean age 75.5 7.12; 54.3% female), of whom 232 and 156 were included in the full analysis set (FAS) and per-protocol (PP) populations, respectively. Due to COVID-19 pandemic, 55% of on-site end-of-treatment effic …
RESULTS: A total of 233 participants were randomised (mean age 75.5 7.12; 54.3% female), of whom 232 and 156 were included in the full analy …
Effects of organic salts of virucidal and antiviral compounds from Nelumbo nucifera and Kaempferia parviflora against SARS-CoV-2.
Yang DD, Chutiwitoonchai N, Wang F, Tian P, Sureram S, Lei X, Mahidol C, Ruchirawat S, Kittakoop P. Yang DD, et al. Sci Rep. 2025 Feb 21;15(1):6380. doi: 10.1038/s41598-025-89736-0. Sci Rep. 2025. PMID: 39984611 Free PMC article.
Among these flavonoids, only 5,7,4'-trimethoxyflavone (8) was found to show virucidal (EC(50) 437.90 M) and antiviral (EC(50) 50.97 M) activities against SARS-CoV-2. However, flavonoids (5-13) did not inhibit SARS-CoV-2 3CL(pro) enzyme at …
Among these flavonoids, only 5,7,4'-trimethoxyflavone (8) was found to show virucidal (EC(50) 437.90 M) and antiviral (EC(50) 50.97 M) activ …
81 results